Skip to content

Exposure to per- and polyfluoroalkyl substances, genetic variations of key genes in Keap1/Nrf2 pathway, and their interaction effects associated with hypertensive disorders of pregnancy and related mechanisms

Exposure to per- and polyfluoroalkyl substances, genetic variations of key genes in Keap1/Nrf2 pathway, and their interaction effects associated with hypertensive disorders of pregnancy and related mechanisms

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200061756
Enrollment
Unknown
Registered
2022-07-02
Start date
2023-01-01
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy-induced hypertension

Interventions

Sponsors

Guangdong Women and Children Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: 1. Inclusion criteria of cases: The cases included in this project are pregnant women who meet the clinical diagnostic criteria of "Guidelines for the Diagnosis and Treatment of Hypertensive Diseases in Pregnancy" and were diagnosed by doctors as gestational hypertension, preeclampsia or eclampsia. (1) The diagnostic criteria for gestational hypertension are: hypertension for the first time after 20 weeks of pregnancy, systolic blood pressure >= 140 mmHg and/or diastolic blood pressure >=90 mmHg; urine protein test is negative. (2) The diagnostic criteria for preeclampsia are: systolic blood pressure >= 140 mmHg and/or diastolic blood pressure >= 90 mmHg with proteinuria >= 0.3 g/24 hours or random urine protein >= (+) after 20 weeks of gestation; no proteinuria but with any of the following organs or systems are involved: heart, lung, liver, kidney and other vital organs, or abnormal changes in the blood system, digestive system, nervous system, placenta-fetal involvement, etc. (3) The diagnostic criteria for eclampsia are preeclampsia based on tonic convulsions that cannot be explained by other causes. 2. Inclusion criteria for the control group: healthy pregnant women without pregnancy-induced hypertension after clinical examination and doctor's diagnosis, matched 1:2 with the case group according to the time of entering the cohort and the age of the pregnant women.

Exclusion criteria

Exclusion criteria: 1. Non-Han nationality; 2. Those with a history of potential occupational exposure to PFASs (verified by questionnaire); 3. Those with chronic hypertension, diabetes, kidney disease or autoimmune disease; 4. Those with a history of pregnancy-induced hypertension in the past delivery history ; 5. Those who have a family history of gestational hypertension or family history of hypertension; 6. Those whose pregnancy outcome is miscarriage, stillbirth, multiple births or birth defects.

Design outcomes

Primary

MeasureTime frame
per- and polyfluoroalkyl substances;

Secondary

MeasureTime frame
Genetic variants in Keap1/Nrf2 pathway;

Countries

China

Contacts

Public ContactWeixiang Wu

Guangdong Women and Children Hospital

samwoowu@163.com+86 18933931022

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026